| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.06 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |